BioSig Technologies, Inc. announces its intention to offer shares of common stock through an underwritten public offering.
The company plans to use the net proceeds from the offering to purchase gold bullion, for working capital, and general corporate purposes.
Clear Street and Needham & Company are acting as joint book-running managers of the offering.
Offering Details
Offering shares of common stock through an underwritten public offering with the net proceeds intended for specific uses.
Book-Running Managers
Clear Street and Needham & Company are the joint book-running managers of the offering.
Registration Statement
The offering is made pursuant to a shelf registration statement on Form S-3 (File No. 333-276298) declared effective by the SEC on December 17, 2024.
- The completion of the offering is subject to market conditions, with uncertainties regarding timing, size, and terms.
- Interested parties should read the preliminary prospectus supplement and other documents filed with the SEC for complete information about the offering.
BioSig Technologies Inc. aims to utilize the proceeds from the public offering strategically for investments, working capital, and overall corporate purposes, highlighting a potential shift in the company's financial strategies.